tiprankstipranks
Biogen (BIIB)
NASDAQ:BIIB
Holding BIIB?
Track your performance easily

Biogen (BIIB) Ownership - Who Owns Biogen?

4,581 Followers

Biogen (BIIB) Ownership Overview

0.14%35.90%24.41%32.22%7.32%
24.41% Other Institutional Investors
32.22% ETFs
7.32% Public Companies and Individual Investors
The ownership structure of Biogen (BIIB) stock is a mix of institutional, retail, and individual investors. Approximately 92.54% of the company’s stock is owned by Institutional Investors, 0.14% is owned by Insiders, and 7.32% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 05, 2024
Priya Singhal
Head Of Development
xxxxxxxxxxxxx
$88019
Feb 26, 2024
Priya Singhal
Head Of Development
xxxxxxxxxxxxx
$57962
Feb 21, 2024
Priya Singhal
Head Of Development
xxxxxxxxxxxxx
$23921
Feb 20, 2024
xxxxxxxxxxxxx
$101256

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
16,315,079Institution11.20%2,577,945,633
15,131,733Institution10.38%2,390,965,131
13,826,526Institution9.49%2,184,729,373
9,155,411Institution6.28%1,446,646,492
7,827,277Institution5.37%1,236,788,039
6,668,195Institution4.58%1,053,641,492
6,340,143Institution4.35%1,001,805,995
5,299,067Institution3.64%837,305,577
4,558,453Institution3.13%720,281,159
2,448,859Institution1.68%386,944,211

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
13,826,526Institution9.49%2,184,729,373
9,155,411Institution6.28%1,446,646,492
4,558,453Institution3.13%720,281,159
2,448,859Institution1.68%386,944,211
2,344,787Institution1.61%370,499,794
2,199,389Institution1.51%347,525,456
1,928,777Institution1.32%304,766,054
1,367,767Institution0.94%216,120,864
1,300,000Institution0.89%205,413,000
1,034,683Institution0.71%163,490,261

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
4,601,770Institution3.16%800,707,980
3,862,286Institution2.65%672,037,764
3,090,416Institution2.12%537,732,384
2,846,653Institution1.95%449,799,641
1,825,977Institution1.25%283,811,605
1,808,089Institution1.24%282,061,884
1,626,008Institution1.12%256,925,524
1,237,030Institution0.85%215,243,220
1,001,632Institution0.69%174,283,968
1,076,824Institution0.74%167,984,544

FAQ

Who Owns Biogen (BIIB)?
According to the latest TipRanks data, approximately 24.41% of the company's stock is held by institutional investors, 0.14% is held by insiders, and 7.32% is held by retail investors.
    What percentage of Biogen (BIIB) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 24.41% of Biogen (BIIB) stock is held by institutional investors.
      What percentage of Biogen (BIIB) stock is held by retail investors?
      According to the latest TipRanks data, approximately 7.32% of Biogen (BIIB) stock is held by retail investors.
        Who owns the most shares of Biogen (BIIB)?
        Theofanis Kolokotrones owns the most shares of Biogen (BIIB).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis